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Abstract
Meat, including fish and shellfish, represents a valuable constituent of most balanced diets. Consumption of
different types of meat and fish has been associated with both beneficial and adverse health effects. While white
meats and fish are generally associated with positive health outcomes, red and especially processed meats have
been associated with colorectal cancer and other diseases. The contribution of these foods to the development or
prevention of chronic diseases is still not fully elucidated. One of the main problems is the difficulty in properly
evaluating meat intake, as the existing self-reporting tools for dietary assessment may be imprecise and therefore
affected by systematic and random errors. Dietary biomarkers measured in biological fluids have been proposed as
possible objective measurements of the actual intake of specific foods and as a support for classical assessment
methods. Good biomarkers for meat intake should reflect total dietary intake of meat, independent of source or
processing and should be able to differentiate meat consumption from that of other protein-rich foods;
alternatively, meat intake biomarkers should be specific to each of the different meat sources (e.g., red vs. white;
fish, bird, or mammal) and/or cooking methods. In this paper, we present a systematic investigation of the scientific
literature while providing a comprehensive overview of the possible biomarker(s) for the intake of different types of
meat, including fish and shellfish, and processed and heated meats according to published guidelines for biomarker
reviews (BFIrev). The most promising biomarkers are further validated for their usefulness for dietary assessment by
published validation criteria.
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Background
Meat, including fish and shellfish, represents a valuable
constituent of a balanced omnivorous diet. The import-
ance of meat from a nutritional point of view is related
to its high-quality protein content, as it comprises a bal-
anced source of all essential amino acids for muscle
maintenance [1]. Minerals and vitamins, such as iron
and B12 vitamin, and other micronutrients that are es-
sential for growth and development, are additionally
highly bioavailable from meat compared to other sources
[2]. Meat processing, such as curing, smoking, or heat-
ing, further improves its organoleptic properties, as well
as its microbiological safety and shelf life [3]. On the
other hand, high consumption of processed meat and
possibly red meat has been associated with a series of
adverse health outcomes, including cardiovascular dis-
ease (CVD) [4], overall mortality [5], and certain types of
cancer, especially colorectal cancer [6–8]. However, re-
cent large, prospective investigation including almost
half a million subjects from ten European countries [9],
only found significant associations with processed meat
intake. Poultry was not related to all-cause mortality,
whereas red meat was related to higher all-cause mortal-
ity only before correcting for potential confounding [9].
Additionally, high intake of red and processed meat has
also been associated with an increased risk of developing
type 2 diabetes, although major inconsistencies regard-
ing consumption levels exist between studies [10–12].
Fish and shellfish intake has been associated with posi-
tive health outcomes, such as decreasing CVD risk [13]
and possibly colorectal cancer [14, 15], while its role in
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preventing type 2 diabetes development is still unclear
[16, 17]. Different outcomes in the studies may also as-
sociate with the type of fish consumed and the cooking
methods [17]. Moreover, aquatic meat has proven to be
one of the major dietary sources of contaminants that
are potentially harmful to human health, such as methyl-
mercury and arsenic [18, 19].
Since associations are always debatable in terms of
cause and effect and weak associations like those be-
tween meat and chronic disease are always at a high risk
of being affected by bias or confounding, it is important
to find biomarkers able to objectively discriminate be-
tween different classes of meat, particularly red meat,
white meat from poultry, white meat from fish or shell-
fish, and processed meats [20]. The existing self-
reporting tools for dietary assessment, such as food
frequency questionnaires (FFQ) and dietary records, are
imprecise and can be affected by systematic and random
errors, especially when a certain food is perceived as
healthy or unhealthy [21]. Dietary biomarkers have been
proposed as possible objective measurements of the ac-
tual specific food intakes or at least as a support for the
classical assessment methods [22]. A good marker of
overall meat intake should reflect total dietary meat in-
take differentiating any meat consumption from that of
other protein-rich foods; additional markers should dis-
criminate between different meat sources (e.g., red vs.
white or between different species, e.g., pork vs. beef)
and identify cooking methods. In this paper, we present
the results of a systematic search of the scientific litera-
ture according to the BFIrev methodology [23] providing
a comprehensive overview of the possible marker(s) for
the intake of different meat types, including fish and
shellfish. The most promising biomarkers are further
validated according to a validation scheme previously
proposed for biomarkers of food intake [24]. This review
represents the continuation of the reviewing process for
candidate intake biomarkers for various foods of animal
origin initiated in a previous paper on dairy and egg bio-
markers, as part of the FoodBAll project [25].
Methods
Selection of food groups
In order to obtain a good coverage of the different meat
sources, meat was subdivided into fresh meat (e.g., over-
all meat intake, red meat, white meat), fish and fish oil,
and other aquatic meat, e.g., various shellfish, processed
meat products (cured and smoked), and offal or organ
meats. Two particular groups, strongly heated (e.g.,
grilled) meat products and biomarkers for fish contami-
nants, were also investigated. A total of nine food groups
were thus selected for reviewing their respective markers
of intake. A systematic literature search was carried out
separately for each food group as detailed below.
Primary literature search
The reviewing process, including article search and se-
lection, reviewing and reporting of the results, follows
the guidelines previously proposed by the FoodBAll con-
sortium to carry out an extensive literature search and
evaluation of biomarkers for food intake (BFIs) [23].
In brief, original research papers and reviews were
searched in at least two databases, among which
PubMed, Scopus, and ISI Web of Knowledge, using
combinations of the grouped search terms (biomarker*
OR marker* OR metabolite* OR biokinetics OR bio-
transformation) AND (trial OR experiment OR study
OR intervention OR cohort) AND (human* OR men OR
women OR patient* OR volunteer* OR participant*)
AND (urine OR plasma OR serum OR blood OR excre-
tion) AND (intake OR meal OR diet OR ingestion OR
consumption OR eating OR drink* OR administration),
as reported in Additional file 1: Table S1, together with
specific keywords related to each animal-derived food
group (Additional file 1: Table S2). The fields used as
default for each of the databases were [All Fields] for
PubMed, [Article Title/ Abstract/ Keywords] for Scopus,
and [Topic] for ISI Web of Science, respectively. For al-
most all food groups, the three databases were con-
sulted. For “processed meat” and “offal meat,” the search
was carried out only in PubMed and ISI Web of Know-
ledge. The literature search process was carried out be-
tween November and December 2015 and updated at
the end of December 2018 for all food groups.
The search was limited to papers written in English, while
no restriction was applied regarding publication date. The
research papers identifying or using potential biomarkers of
intake for the different kinds of meat were selected from
the list of retrieved references by one or more skilled re-
searchers in a process outlined in Additional file 1: Figure
S1. The papers obtained from the search in different data-
bases were merged and filtered for duplicates. Subse-
quently, papers were screened based on title and abstract.
The selected papers were then retrieved and assessed for
eligibility based on the contents of the whole manuscript.
Additional papers were identified from reference lists in
these papers and from reviews or book chapters identified
through the search. The result was a list of compounds po-
tentially relevant as biomarkers for the food group and cor-
responding references.
Secondary search, marker identification, and classification
A second search step was used to evaluate the apparent
specificity of the markers in the list. The compound da-
tabases HMDB [26] and FooDB (http://foodb.ca/)) were
used for a first evaluation of marker specificity. If the
marker was not specific for a single food group, it was
noted whether it was related to any food outside the
meat food groups. In the latter case, unless levels were
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reported to be very low elsewhere, the compound was
omitted from the list for the next search. The remaining
list of putative biomarkers was used for a second litera-
ture search in the three bibliographic databases used also
for the primary search. This was done to potentially
identify other foods containing the putative biomarkers
or their precursors as well as foods otherwise associated
with these compounds. For the second web-search, we
used the chemical name(s) of the marker as keyword, to-
gether with AND (biomarker* OR marker* OR metabol-
ite* OR biokinetics OR biotransformation). Further
filters, such as (urine OR plasma OR serum OR blood
OR excretion) AND (intake OR meal OR diet OR inges-
tion OR consumption OR eating OR drink* OR adminis-
tration) AND (human* OR men OR women OR patient*
OR volunteer* OR participant* OR subject*), were added
based on the results obtained. Again, markers not re-
lated to meat intake were deleted from the list. The
remaining putative markers with potential specificity for
each food group or for several combined animal food
groups were finally listed in Additional file 2: Table S3,
together with information about the study designs of the
papers reporting their use. Due to the high number of
results on marine fatty acids from the search on “fish
and fish oil,” only the most representative among the ob-
servational studies having the highest number of partici-
pants were kept in Additional file 2: Table S3. A
summary of the markers considered for further valid-
ation according to the validation guidelines [24] is re-
ported in Additional file 3: Table S4.
Marker validation
In order to further assess the validity of the candidate
biomarker, the scoring system for biomarkers of food in-
take was used as described previously [24]. Briefly, the
usefulness of each selected marker in Additional file 3:
Table S4 has been established by answering a set of sim-
ple questions reflecting the biological and analytical cri-
teria that a biomarker should fulfill in order to be
considered valid. The questions have been answered for
the most promising biomarkers. Possible answers were Y
(yes), N (no), or U (unknown or uncertain). Each candi-
date marker was evaluated for plausibility (question 1),
meaning that it is considered a plausible BFI for the food
or food group based on food chemistry; dose-response
relationship between quantity of food ingested and bio-
marker response (question 2); kinetics of immediate
postprandial response (question 3a) and/or of repeated
intakes (question 3b); robustness in complex diets or
real-life exposure situations (question 4); reliability, i.e.,
concordance with other established measures of intake
for the food or food group in question (question 5); ana-
lytical aspects, including the chemical stability of the
marker (question 6), its analytical performance (question
7); and reproducibility in different labs (question 8) [24].
Results
General biomarkers of meat intake
General biomarkers of meat intake are common to all or
a large number of foods investigated in this review. The
search for biomarkers of meat intake provided 953 hits
after removal of duplicates, resulting in the final selec-
tion of 20 papers from the web-search (Additional file 1:
Figure S1). From the analysis of the reference lists and
from the secondary search, another six papers were in-
cluded in the review, resulting in a total of 26 papers;
several relevant papers were dealing with specific meat
subgroups and were therefore moved to this heading
after reading the full text papers (Additional file 2: Table
S3). The main markers associated with the intake of ani-
mal protein from meats were various isotope ratios, an-
serine, carnosine, 1- and 3-methylhistidine (MH),
creatine, creatinine, carnitine and acylcarnitines, taurine,
trimethylamine oxide (TMAO), and several unidentified
features specified by their m/z ratio. In addition, urinary
nitrogen was used for total protein intake assessment in
many studies but the marker is not a specific meat in-
take biomarker and therefore not included. The main
human sample investigated in the studies was urine,
followed by plasma, although feces and hair were also
used occasionally. Both interventional and observational
studies were considered for the evaluation of the puta-
tive BFIs for meat intake.
Histidine-related compounds
Vertebrate muscles contain a large amount of dipeptides
containing histidine, such as carnosine (β-Alanyl-L-histidine),
anserine (β-Alanyl-3-methyl-L-histidine), and balenine (β-Al-
anyl-1-methyl-histidine); therefore, the quantification in hu-
man bio-specimens of such compounds or products of their
catabolism, such as β-alanine, 1-MH (Nτ-MH) and 3-MH
(Nπ-MH), may support the assessment of meat intake [20].
Some degree of confusion exists regarding the nomenclature
of 1-MH and 3-MH in regards to the numbering of the ni-
trogen in the imidazole ring of the histidine moiety because
chemists and biochemists have used opposite designations
for the two molecules; for instance, PubChem lists both
compounds with both names and with both synonyms. We
use here the chemical nomenclature, where Nπ-MH (π for
nearest to the side chain) is termed 3-methylhistidine, while
the common form in human muscle, Nτ-MH (t for far from
the side chain) is termed, 1-methylhistidine, as recom-
mended in the IUPAC definition and in the major com-
pound databases [26, 27]. The synonym of the dipeptide
anserine is thus β-Alanyl-3-methyl-L-histidine (Mora et al.
2007; HMDB metabocard for anserine (HMDB00194)); how-
ever, while some older papers have termed it β-Alanyl-1-
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methyl-L-histidine, in this review we have reported the re-
sults from these papers with the IUPAC name [28, 29]. The
dipeptide anserine, common in poultry, undergoes cleavage
to give rise to 3-MH. The dipeptide balenine, common in
some whales, cleaves to form 1-MH [30].
The content of histidine-containing dipeptides in food
is highly variable [31–33] and their use as markers for
meat intake may therefore be better at the group level
than at the individual level. Carnosine contents are
higher in beef and pork, while they are slightly lower in
poultry [31, 33] and almost absent in fish, with the ex-
ception of some species of Anguilloidei (eel) [32]. More-
over, this compound was not detected in other foods of
animal origin, such as milk [34] and may only be found in
some sources of liver [35, 36], suggesting that the com-
pound could represent a putative marker to assess the in-
take of terrestrial meat. Carnosine levels were found to be
markedly increased in urine after the ingestion of beef,
pork, chicken, and eel [31, 34, 37, 38], showing also dose-
response [34]. Cheung et al. [38] further compared several
meat sources and reported that urinary carnosine associ-
ates with meat intake in a selected group of subjects from
the European Prospective Investigation into Cancer and
Nutrition (EPIC). Carnosine levels were significantly
higher in the urine samples from subjects who consumed
chicken, red meat, and processed meat compared to those
consuming fish, with no significant differences observed
between subjects consuming similar amounts of the three
types of meat. Carnosine is completely excreted in urine
within 20–25 h following the meal, reaching a peak after 5
h [31]. This kinetic behavior makes the compound suit-
able for quantification in 24 h urines to estimate total in-
take of terrestrial muscle meat.
The results regarding the detection of carnosine in
plasma are contradictory. Parker et al. [39] observed a
peak in plasma at 2.5 h after beef consumption returning
to background levels after 5.5 h, while other studies
failed to confirm this [37, 38]. In a cross-sectional study
of 294 Bavarian men and women completing 24-h recalls
and providing non-fasting samples, plasma carnosine
was associated with intake levels for all meat, red meat,
and beef + pork but not for poultry, fish, or dairy [40]
with approximately similar intake levels. These discrep-
ancies could therefore be ascribed to a possibly weak
performance of this marker, even at the group level.
Plasma carnosine needs to be further investigated in
carefully controlled trials to evaluate its usefulness as a
BFI. With the current evidence, plasma carnosine is not
a likely candidate marker for meat intake.
Anserine is present in the muscles of different non-
human vertebrates, with poultry, rabbit, tuna, plaice, and
salmon having generally higher contents than other mar-
ine foods, beef, or pork [31–33, 41]. An increase of urin-
ary anserine excretion was found in humans after the
consumption of chicken [31, 37, 38], rabbit [41], and
tuna [31] and has been associated with intake of chicken
[38], salmon [42], and, to a lesser extent, beef [34], while
other observational evidence indicates no increase with
fish intake [38]. In particular, anserine in urine was a
good marker for chicken intake based on FFQ data in a
selected sample of high vs. non-consumers from the
EPIC study [38].
In a cross-sectional study from Bavaria, plasma anserine
was associated in a dose-response manner with 24-h recall
information for total meat, beef + pork, turkey, processed
meat, and total dairy but not with chicken, total poultry,
“seafood,” or beef or pork, individually [40].
In the human body, anserine is a substrate for carnosi-
nase and is mainly degraded and excreted as 3-MH [31].
Endogenous formation of 3-MH is minimal in humans;
therefore, plasma and urinary 3-MH are primarily associ-
ated with food intake. A significant increase in the level of
urinary 3-MH was observed after consumption of red meat
[34, 43, 44], chicken or poultry [31, 34, 38, 44–46], and fish
[31, 38, 42, 44, 47], with a clear dose- or time-response rela-
tionship between urinary 3-MH excretion and the intake of
the different animal proteins [38, 43, 44, 46]. Urinary 3-MH
was able to discriminate subjects with vegetarian or omniv-
orous diets in controlled settings [43] as well as in free liv-
ing subjects [48], suggesting that this marker could provide
evidence of overall habitual meat intake. Importantly, the
excretion of 3-MH depends on meat source. In studies
reflecting recent intake, poultry intake gave higher levels of
3-MH when compared to those following consumption of
pork and/or beef, most likely due to anserine breakdown
[34, 38, 44]. The discrimination between poultry and fish
intake is more uncertain, as fish species vary significantly in
anserine and 3-MH content [32, 44], but chicken meat
seems to have generally higher levels than fish. An in-
creased level of 3-MH was reported after consumption of
chicken compared to that of cod [38]. In one observational
study from the Adventist Health Study-2 cohort (n = 1011
subjects), urinary 3-MH was positively associated with the
intake of animal protein, red meat, and poultry, assessed
both by FFQ and 24-h recall, while the correlation tended
to be lower with fish, probably due to the preference for
meat consumption in the population investigated [49]. On
the other hand, Cheung et al. [38] observed higher concen-
tration of 3-MH in the urine of a subset of EPIC subjects
who consumed fish (mainly cod and haddock) compared to
those consuming red and processed meat. Also in this case,
poultry intake gave the highest amount of 3-MH excretion.
3-MH peaks in urine around 5 h after intake and decreases
to baseline levels after ~ 40 h [31] or 48 h [50]. Sjolin et al.
[44] reported an excretion half-life of 11.7 h for 3-MH, in-
dicating that excretion would not be complete in a 24-h
urine collection. In a recent study, ten healthy subjects
ingested increasing amounts of chicken daily for 3 days in
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three consecutive weeks. Peak postprandial plasma levels
on day 3 and fasting levels in urine and plasma on day 4 in
each week increased with dose [46] corroborating accumu-
lation of 3-MH with daily intakes. 3-MH was also detected
in plasma samples after the intake of chicken and to a lesser
extent after the consumption of fish in another controlled
intervention study [38]. A much smaller increase was also
observed after intake of beef and processed meat. Urinary
and plasma 3-MH therefore represent possible markers to
assess meat intake, but due to the differences between meat
sources with higher levels observed after intake of chicken
and some species of fish, the marker should be carefully
evaluated for different study populations, based on their
food preferences.
1-MH is a constituent of actin and myosin, the contract-
ile proteins of skeletal muscles, and its urinary excretion is
rapid following muscle protein breakdown [51]. This com-
pound has been observed to significantly increase in urine
after meat consumption [43, 52–54]. A single meal with
15N-labeled beef increased 15N-labeled 1-MH in urine at
0–8 h, confirming that food-derived 1-MH is excreted in
urine [55]. Unlike 3-MH, the excretion of 1-MH increased
during 72 h of fasting indicating catabolism of muscle tis-
sue [56]. Daily meat intake in omnivores associates with
1-MH excretion, however with much more variation com-
pared to 3-MH [34, 44], although with a similar postpran-
dial kinetics and a half-life of 12.6 h [44]. Endogenous
production causes a high inter-individual variability mak-
ing this marker less suitable to asses meat intake by itself
[43]. In one observational study, urinary 1-MH after meat
and fish intake was not different between high and non-
consumers [38]. Plasma 1-MH was not associated with
any group of meat, poultry, or fish intake in a study based
on 24-h recalls [40] and did not increase after a meal
intervention with chicken breast [50].
As a consequence of the breakdown of histidine-containing
dipeptides, β-alanine can also be observed in body fluids [41].
So far, only one metabolomics study reported an increase in
plasma levels of this compound after beef consumption [57].
In an early study, β-alanine appeared to increase in human
urine only after an anserine containing meal [41], but since β-
alanine can also be formed endogenously by catabolism of py-
rimidines [26], it may not be a robust marker to assess meat
intake; further investigations are necessary to evaluate its spe-
cificity and sensitivity in a cross-sectional study.
Carnitine and acylcarnitines
Carnitine represents an essential cofactor in fatty acid
metabolism in mammals, as it transports fatty acids
under the form of acylcarnitines into the mitochondria
of muscle cells for cellular energy production by lipid β-
oxidation [58]. Carnitine may be synthetized in the body
from the essential amino acids lysine and methionine.
Most of the carnitine in omnivores comes from dietary
sources, particularly beef and lamb [20]. Carnitine and
acetylcarnitine were higher in the urine [59] and serum
[60] of subjects consuming high-meat diets compared to
vegetarians, and their urinary values were representative
of habitual intake of red and processed meat in free-
living subjects [61, 62]. Three acylcarnitines (acetylcarni-
tine, propionylcarnitine and 2-methylbutylcarnitine)
were significantly higher in the urine of subjects from
the EPIC cohort after the intake of meat and fish com-
pared to control subjects with no meat intake, with no
distinction among the different animal protein sources
[38]. Propionylcarnitine and acetylcarnitine were also
observed in plasma after a dietary intervention with
meat and fish from the same research group [38]. Acet-
ylcarnitine had slower kinetics than propionylcarnitine,
reaching the highest value after 24 h when propionylcar-
nitine had already returned to the baseline level. In the
EPIC-Oxford cohort, a series of acylcarnitines were also
characteristic of the dietary pattern associated with high
meat intake [63]. In particular, the concentrations of car-
nitine and acylcarnitines C-4 and C-5 were highest in
meat eaters, followed by fish eaters, vegetarians, and
vegans. Furthermore, C-3 and C-16 were higher in meat
eaters and lower in vegans. Carnitine and acylcarnitines
may reflect the intake of highly accessible amino acids
and fatty acids contained in meat and fish and may be
considered generic markers of intake of foods of animal
origin. However, given that physiological conditions such
as age, gender, and health status, as well as the intake of
other foods with highly accessible amino acids or fatty
acids may affect plasma acylcarnitine levels and their ex-
cretion into urine [64, 65], these metabolites may not be
suitable markers per se for specific and quantitative as-
sessment of meat intake and are therefore not consid-
ered for further validation as single markers.
Creatine and creatinine
Creatine is present in animal muscles, mainly in the
form of phosphocreatine, and can be synthesized en-
dogenously from arginine, glycine, and methionine. The
main dietary source is meat, including red meat, fish,
and poultry [66]. Several studies reported an increase in
creatine levels after meat intake in urine [59, 62, 67, 68],
erythrocytes [60], plasma, and serum [60, 69, 70]. Even a
single meal containing meat has been shown to increase
creatine in urine [71]. Associations between urinary cre-
atine and habitual intake of shellfish [62] and oily fish
such as salmon [42] have also been reported. Pallister
et al. [69] proposed circulating levels of creatine as a
possible marker of habitual intake of red meat and
poultry, as observed in the UK Twin cohort study (n =
3559 subjects). However, experimental studies support-
ing this observation are lacking. Creatine in urine and
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plasma/serum are therefore candidate markers of total
meat intake.
Creatinine can originate both from spontaneous decom-
position of creatine and creatine phosphate in the human
body and to some extent also during cooking of meat [72].
An effect of diet on urinary creatinine was observed in a
study comparing omnivores and vegetarians, being higher
in the former group [60]. Cross et al. [43] showed that
urinary creatinine performed as a food intake biomarker
only for extreme levels of meat intake. Creatinine excre-
tion mainly reflects endogenous production. The excre-
tion into urine is highly regulated in the body and is
proportional to the total content of creatine and creatine
phosphate, i.e., the total muscle mass, in individuals with
normal kidney function [20]. Therefore, creatinine cannot
be used to estimate intake of meat without correcting for
muscle mass and the compound is consequently not gen-
erally useful as a meat intake biomarker.
Taurine
Taurine is the most abundant free amino acid in animal
tissues and mainly derives from the ingestion of many
different foods of animal origin including eggs and dairy,
while it can also be synthetized endogenously [73].
Metabolomics studies reported higher urinary taurine in
omnivorous subjects compared to vegetarians [59, 74].
In two intervention studies, taurine excretion increased
with animal protein intake but the change was not sig-
nificant for low levels of meat intake [43, 75]. Taurine
also associated with shellfish intake in an observational
study (n = 253 subjects), but not with general meat in-
take [62]. The marker does not appear robust enough to
assess total meat intake.
Trans-4-hydroxyproline
Hydroxyproline (Hyp) is a post-translationally modified
amino acid that represents a major component in pro-
tein collagen and elastin, and its main dietary source
comes from animal foods rich in connective tissue [76].
This compound was found in plasma after the intake of
beef [57], while Pallister et al. [69, 70] observed a signifi-
cant correlation between the level of this compound in
fasting blood and the frequency of meat and processed
meat consumption in the UK Twin cohort. High levels
of collagen have also been reported in fish [77], therefore
it can be speculated that this marker may better reflect
the overall intake of meat rich in collagen, rather than
that of red or processed meat. The dipeptide prolyl-
hydroxyproline (Pro-Hyp) has been reported as a marker
of a healthy diet rich in fish [78]. Since there is also col-
lagen in offal meat, HyP in plasma is a potential intake
marker of total meat intake. Further studies of the con-
tribution of endogenously formed HyP to its urinary ex-
cretion is needed as well as studies on HyP containing
dipeptides in plasma and urine to potentially discrimin-
ate between endogenous and dietary sources.
δ15N and δ13C
Recently, the ratios of naturally occurring stable isotopes
of carbon (13C/12C ratio, expressed as δ13C) and of ni-
trogen (15N/14N ratio, expressed as δ15N) in biological
fluids and tissues have been proposed as novel nutri-
tional biomarkers of meat and fish intake. Such an ap-
proach was originally used in archeology and recently
introduced also in nutritional science to support dietary
assessment of animal proteins [79]. When animals con-
sume plants, they incorporate carbon and nitrogen from
plants into their own tissues. The abundance of δ13C
depends on the photosynthetic process utilized by the
plants consumed by the animals; hence, animal feeding
represents the primary determinant of variation in ani-
mal δ13C values [79]. In particular, C4 plants (crabgrass,
sugarcane, and corn) have δ13C values 12–13‰ higher
than C3 plants (wheat, rice, and the majority of fruit and
vegetables). Incorporation of 15N depends also on dietary
sources. In particular, animals preferentially excrete 14N
as waste nitrogen, leading to δ15N values that are 3‰ to
4‰ higher than in their diet [79]. Moreover, 15N abun-
dance of tissue proteins increases in the food chain. As a
consequence, animal-derived food proteins are expected
to have a higher amount of 15N compared to plant-
derived protein food. In particular, the δ15N value has
been suggested as a particularly good marker for aquatic
meat consumption, as commonly consumed fish, such as
tuna, salmon, and cod, are predators and reside at the
higher levels of the trophic chain [80].
In a randomized 4 × 8 days cross-over study, Kuhnle
and coworkers [81] observed significantly different iso-
tope ratios among different diets (meat, fish, half-meat–
half-fish, and vegetarian) in feces and urine samples, but
not in blood samples, possibly due to the slower protein
turnover. Higher δ13C and δ15N were observed in urine
and fecal samples following a fish diet, and lower follow-
ing a vegetarian diet, where protein had been substituted
by carbohydrates. It was not possible to distinguish be-
tween meat and half-meat–half-fish diets in any of the
biofluids. The higher level of δ13C and δ15N after the
fish diet may be ascribed to the high level of fish that
the subjects consumed during the intervention period.
These results suggest that urinary and fecal δ13C and
δ15N may be suitable biomarkers to assess short-term
meat and fish intake, while blood levels may reflect
longer-term intake. This interpretation is supported by
data from Patel et al. [82], who were able to distinguish
vegetarian from non-vegetarian subjects by serum δ13C
and δ15N abundance in a sub-cohort within the EPIC-
Norfolk study (n = 1254). Serum δ13C and δ15N were
positively associated (P < 0.001) with fish protein intake
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(assessed by FFQ) and increased with increased fish con-
sumption, while animal proteins, including dairy and
meat proteins, were significantly associated with δ15N.
Serum δ15N increased also with total animal protein
consumption. Overall fish intake is more clearly associ-
ated with the isotope ratios in populations with high fish
intakes while the ratios cannot distinguish different
sources of intake in populations with mixed diets of
aquatic and terrestrial meats [80, 83–85].
To monitor the habitual intake of animal proteins,
δ15N and δ13C were measured in hair and compared
with the data collected from FFQ and dietary records in
observational studies [86–89]. This is possible as hair
keratin is not recycled in the body, and allows a reliable
recording of dietary habits during the past months [86].
Overall δ15N and δ13C in hair are positively associated
with total meat intake and no specific meat group seems
to be dominant, except when either fish or terrestrial
meats dominate the diet [86, 90].
In conclusion, δ15N alone or in combination with
δ13C represent promising markers to assess animal pro-
tein as well as meat intake, both for short-term based on
urine or feces and habitual intake based on blood and
hair. As these ratios are affected by local diets and agri-
culture, they should be validated for each population be-
fore being applied.
TMAO
The intake of red meat has been mentioned as a cause
of increased plasma or urine levels of TMAO in some
observational studies [91, 92], while increased levels are
characteristic of fish or shellfish in intervention studies.
In cross-over randomized controlled trials (RCTs) com-
paring meals with beef, egg, fruit, and cod, urine or
plasma levels increased only with cod [38, 93–95].
Plasma TMAO, trimethylamine (TMA), and dimethyla-
mine increased quickly after cod with a peak at 2 h. Beef
and egg slightly increased postprandial plasma TMAO
and the volunteers segregated into TMAO producers
and non-producers, based on their microbiota [94]. In
an intervention study comparing 4-week intakes of red
meat, poultry, or non-meat proteins with levels of
TMAO in plasma and urine, TMAO excretion as well as
plasma levels increased only with red meat. A subset of
13 volunteers received isotope-labeled carnitine and
betaine but only carnitine increased circulating isotope-
labeled TMAO [96]. In conclusion, TMAO in urine does
not seem to be a marker of recent red meat intake but is
increased postprandially with certain types of fish (see
section below). The microbial formation of TMA and its
hepatic oxidation to TMAO increase plasma levels by
2–4-fold in subjects with a pre-disposing microbiota
after diets rich in TMA precursors, including carnitine.
However, plasma TMAO cannot serve as a marker of
red meat intake because the response varies between in-
dividuals and may also depend on the efficiency of the
kidney in removing it from the circulation.
Mammalian (red) meat
Red meat includes muscle meat from mammals, although
the amount of color (heme) varies considerably between
muscle tissues from different species. Sometimes, the term
pink meat is used to include pork, which has lower con-
tents of heme iron compared to beef, veal, and mutton.
However, we have included pork with the mammalian red
meats here. Although some non-muscle mammalian meats
(e.g., liver) and some fish (e.g., tuna) and poultry (e.g., duck)
have red meat, they are usually not included with the term
and also not included in this category here. The primary lit-
erature search for mammalian red meat in the online data-
bases (Web Of Science, Pubmed and Scopus) resulted in a
total of 1516 articles after the removal of duplicates. The
exclusion of animal studies, studies on nutrition, physi-
ology, and food composition based on title, abstract, or full
text reduced the number of articles to 49. After the evalu-
ation of marker specificity in online databases (HMDB and
FooDB) and from additional literature, 26 putative bio-
markers (lead, indole propionate, xylitol, ethyl glucuronide,
methyl-α-glucopyranoside, sorbitol, cinnamoylglycine, and
a range of lipid species) were excluded from entering the
candidate biomarker list (Additional file 2: Table S3) be-
cause they can also be retrieved in foodstuffs other than
mammalian meat. Based on references retrieved in full text
or secondary sources, three additional articles were added.
As a result, 19 papers were included containing information
on 31 putative biomarkers (including ten unknown metab-
olites) related to red meat intake.
Acylcarnitines, carnitine, 3-dehydrocarnitine, anserine,
β-alanine, 4-hydroxyproline, histidine, 13C/12C, 15N/14N,
carnosine, creatine, 1-MH, and 3-MH have been found to
increase after red meat consumption (Additional file 2:
Table S3), but these compounds or their precursors are
also associated with the overall intake of any meat and
they are therefore not necessarily resulting from intake of
red meat. The products of cooking of meat mentioned in
this review are also unspecific with respect to the type of
meat that is cooked. Therefore, these compounds are not
suited as red meat-specific biomarkers and have been dis-
cussed in the appropriate sections on biomarkers of gen-
eral, cooked, and processed meat intake.
Compounds potentially specific to red meat intake
Only three candidate markers, i.e., ferritin, apparent total
N-nitroso compounds (ATNCs) (a term that encom-
passes nitrosothiols, nitrosyl iron, and other N-nitroso
compounds (NOCs)), and 1,4-dihydroxynonane mercap-
turic acid (DHN-MA), were found as potentially red
meat specific intake biomarkers. This is because these
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compounds may be formed at a significantly increased
level as a consequence of the heme iron content of con-
sumed meat.
Ferritin is a protein that carries and stores iron in the
body, and its abundance in serum is thus related to the
dietary intake of iron. Serum ferritin is more strongly as-
sociated with heme iron than non-heme iron or total
iron intake [97]. However, the influence of other dietary
constituents on iron absorption and serum ferritin con-
centration makes it difficult to use this protein as a bio-
marker for an individual’s red meat consumption and
associations are not consistent in all studies [98–100].
Serum ferritin, therefore, does not seem to be a useful
marker of individual red meat intake.
Heme iron is known to catalyze the formation of nitrite-
derived NOCs associated with the formation of ATNCs.
Heme iron also catalyzes formation of lipid peroxidation
products (e.g., 4-hydroxy-2-nonenal (4-HNE) [101, 102].
The electrophilic nature of 4-HNE causes its conjugation
with glutathione and this adduct is further metabolized
into DHN-MA. Several intervention studies confirm the
positive association between ATNCs and DHN-MA on
the one hand, and heme iron content and/or increasing
doses of red meat on the other hand [101, 103–105].
However, validation of DHN-MA as biomarker for red
meat intake remains insufficient since only eight male
volunteers were included in an intervention study for
DHN-MA [105]. Additional information concerning the
presence of DHN-MA in a larger and more representative
study (e.g., including female test subjects as well) is
needed. Furthermore, the DHN-MA precursor, 4-HNE,
has previously been detected in foodstuffs other than red
meat (e.g., in fish, edible oils, and fried foods [106]), limit-
ing the specificity of DHN-MA as a red meat intake bio-
marker. For ATNCs, three independent intervention
studies have been performed (encompassing a larger group
of volunteers, including female test subjects), confirming
the link between red meat intake and higher ATNCs levels
in stool [101, 103, 104]. However, ATNCs have also been
detected in nitrate or nitrite (as precursors of ATNCs) con-
taining foodstuffs, e.g., cured meat (see section on “proc-
essed meat”), some cheeses, and beer [107, 108],
questioning the use of ATNCs as a qualitative biomarker
for red meat consumption. In addition, the analysis of
ATNCs has been performed by a method involving thermal
release of nitrosamines. In an earlier publication, this heat-
ing process has been shown to lead to artefactual formation
of nitrosamines while no formation of any simple volatile
nitrosamines was detectable [109]. In a study examining
the factors affecting ATNCs, all meats, meat iron, and ni-
trate in the food were directly associated with their forma-
tion while vitamin C and total energy intake were inversely
associated [110]. While ATNCs apparently associate
strongly with red meat intake, the marker still needs
validation by another independent and direct analysis of ni-
trosamines in human feces without the use of thermal sam-
ple treatments. In conclusion, there are currently no
reliable candidate biomarkers of red meat intake.
Offal meat
As reported in Additional file 1: Table S2, the search for
offal meat biomarkers was restricted by the use of
“NOT”-terms to limit the number of irrelevant papers
(the search without these NOT-terms yielded a total
number of > 100,000 papers). With the use of the se-
lected NOT-terms, the search for offal meat biomarker
papers yielded 647 papers in PubMed and 265 in Web
of Science. After combination of the results and elimin-
ation of duplicates, the remaining number of papers was
671. Only a single relevant paper [105] includes two pu-
tative biomarkers for the intake of blood sausage (and
liver paté) in rats and humans: DHN-MA and 8-iso-
prostaglandin-F2alpha (8-iso-PGF2A), which are both
known end products of lipid peroxidation.
Pierre et al. [105] report that urinary levels of 8-iso-
PGF2A and DHN-MA increased in rats after the consump-
tion of blood sausage. An increased excretion of DHN-MA,
but not 8-iso-PGF2A, was subsequently observed in
humans [105]. The results of this small-scale human study
also show a trend toward an increase in DHN-MA after the
consumption of liver paté, although this effect did not ap-
pear to be significant; both blood sausage and liver pate
contain pre-formed 4-hydroxynonenal, which may have
further complicated the interpretation. The authors
ascribed the observed increase of 8-iso-PGF2A and DHN-
MA to the high heme content of blood sausage, corroborat-
ing the potential use of the latter as a candidate heme
intake biomarker. Consequently, any heme-related BFI
would be likely to rise after the consumption of all meat
products rich in heme-iron, including red meat, blood
products, and liver. Neither 8-iso-PGF2A nor DHN-MA is
therefore specifically related to the consumption of offal
meat, although the latter may be a lipid peroxidation prod-
uct more abundant after heme-rich food consumption, as
described above. In conclusion, no candidate biomarkers of
offal meat intake were identified in the literature search.
Poultry
Poultry meat intake includes mainly farmed chicken,
duck, goose, and turkey; however, wild fowl is expected
to have similar markers. The term “white meat” is often
used interchangeably to cover either poultry only, or to
include poultry as well as fish and shellfish. As already
mentioned, some poultry (e.g., duck and fowl) has red-
dish muscle and this is also the case for several species
of larger fish, including tuna. In this review, we have in-
cluded the intake markers for the different meats with
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their biological class of origin and “white” meats in this
section include only poultry.
The literature search performed identified a total of
2311 articles from the three databases. This was reduced
to 2055 articles after removal of duplicates. Sixteen arti-
cles were identified after screening on the basis of title
and abstract. Exclusion criteria for the remaining 2026
articles included effects on physiology; effects on drug
metabolism; articles related to antioxidant markers, dis-
ease/health markers, or oxidative stress markers; and
other articles not relevant to biomarkers of poultry in-
take by humans, such as animal studies. Full texts of the
16 papers were downloaded and assessed further for ex-
clusion/inclusion criteria. Exclusion criteria at this stage
included inappropriate study design, studies on whole
diets or on food preparation, and articles not specific to
poultry meat intake. Eight articles were retained, focused
on poultry products. Additional file 2: Table S3 provides
a summary of remaining candidate biomarkers for
poultry meat. Only studies on chicken or turkey intake
were identified through this search process.
Anserine and methylhistidines
As previously mentioned, we identified a certain degree of
confusion surrounding the nomenclature of 1-MH and 3-
MH. Based on IUPAC nomenclature, 3-MH and not 1-MH
is of interest with respect to poultry consumption [46]. Diet-
ary intake of poultry meat is consistently associated with urin-
ary excretion of 3-MH [44, 111], although a low endogenous
source of this compound (3-MH in the correct nomenclature,
1-MH in the article by Giesecke et al.) may also exist in mam-
mals, including humans [56], leading to a low level of back-
ground 3-MH excretion in all studies. Excretion of 3-MH in
urine [38, 40] as well as peak postprandial plasma levels show
dose-response within normal levels of chicken intake and
plasma 3-MH is still measurable after overnight fasting [46].
The reported levels vary between quantitative studies [40, 46]
indicating analytical issues or instability, and inter-laboratory
comparisons are therefore needed.
The dipeptide, anserine, was reported to increase in
both plasma (Cmax = 2.72 ± 1.08 μM at 100 min) and
urine samples after ingestion of chicken or chicken broth
in healthy women (n = 4) [37]. Plasma anserine has been
associated with poultry intake in a dose-response fashion
and high levels were especially associated with self-
reported ingestion of turkey in a cross-sectional study
from Bavaria [37]. Urinary anserine was particularly asso-
ciated with chicken intake in high versus non-consumers
in a small subset of EPIC participants [38]; however, no
information exists on its excretion kinetics.
Guanidinoacetate, a precursor compound in the biosyn-
thesis of creatine found to increase muscle creatine and
muscle growth in chicken [112], has been found by NMR
analysis in urine as a result of chicken consumption [46].
The compound was found to associate strongly with
chicken intake in an intervention study in the UK and this
finding was confirmed in a cross-sectional study from
Ireland [46]. Guanidinoacetate in urine discriminated intake
of chicken from intake of other meat sources and reflected
chicken intake in a dose-response fashion. In a dietary
study with mixed dairy and meat proteins, including
poultry, provided to Danish boys, guanidinoacetate was also
observed by NMR analysis [113]. Further validation of the
marker is needed from other countries and for other
sources of poultry, in particular to determine if the excre-
tion of this metabolite is in any way a consequence of ani-
mal feeds [114]. Up until then, this marker seems
particularly promising as a unique chicken intake marker.
Several markers were also reported as being associated
with cooking methods such as fried and grilled chicken.
The putative markers PhIP (2-amino-1-methyl-6-pheny-
limidazo[4,5-b]pyridine), MeIQx (2-amino-3,8-dimethyli-
midazol4,5-f]quinoxaline), and their metabolites are
extensively covered in the next section of this review.
Similarly, metabolites related to polycyclic aromatic hy-
drocarbons (PAHs) detected after consumption of grilled
chicken are also reported there. Although levels of these
metabolites are increased following consumption of
cooked chicken, they are also found in other cooked
foods such as fish and beef [115, 116], and consequently
lack specificity. In conclusion, 3-MH and anserine in
urine and plasma should be considered as candidate bio-
markers of poultry intake and guanidinoacetate in urine
as a highly promising marker of chicken intake. Anser-
ine, in particular, will largely benefit from information
on its kinetic profile and dose-response. Overall, add-
itional studies with other poultry meats are needed for
further confirmation and validation of all three markers.
Intake biomarkers for heated meat
Most meat is ingested after cooking; frying, broiling,
baking, and grilling are commonly reported as the most
popular cooking methods for meat products [117]; how-
ever, actual frequencies of different cooking practices are
not often reported. In the search for dietary exposure
markers for fried, broiled, or grilled meat, 391 unique
papers were identified, resulting in 26 selected papers
after the screening process and additionally 13 from the
secondary search and reference lists (Additional file 1:
Figure S1). A total of 39 putative markers for cooked
meet have been identified. All compounds belong to the
families of heterocyclic aromatic amines (HAAs) and
PAHs. One study, based on untargeted metabolomics,
reported a series of pyrraline derivatives which were
positively associated with the heating process, but the
contribution of heated meat could not be separated from
those of other cooked foods [118]. Therefore, such com-
pounds were disregarded in the final table. The final
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putative biomarkers are reported in Additional file 2:
Table S3.
Heterocyclic aromatic amines
HAAs may represent specific markers for the intake of inten-
sively cooked meat, as they are produced during high-
temperature cooking of foods containing creatinine, creatine,
and amino acids, which is the case only for muscle tissue. So
far, more than 25 different heterocyclic aromatic amines have
been found in roasted and fried meat and fish [119, 120].
Their content depends on the cooking method, but it has
been shown that in real-life conditions the most abundant
HAAs are PhIP and MeIQx [120, 121]. Only a small fraction
of the HAAs can be found intact in urine, while the rest
undergo biotransformation, including phase I metabolism by
CYP1A2 and phase II metabolism by acetylation, glucuroni-
dation, and sulphation. As a result, bio-fluids and tissues (e.g.,
urine, stool, blood, or hair) may contain a complex metabolic
pattern reflecting the exposure to specific HAAs [122, 123].
The most reactive metabolites can also covalently bind DNA
or proteins, producing adducts, which can be detected in
DNA or tissue as well as in urine after DNA-repair or protein
degradation [122, 124]. The use of adduct markers is limited
due to the low abundance of these compounds and the inva-
sive techniques sometimes required to collect the relevant tis-
sue. Indeed, the majority of these investigations have been
conducted on biopsy samples of patients that were obtained
during clinical diagnosis of cancer [122]. However, some stud-
ies also used blood protein adducts to albumin or erythrocyte
globin [124].
Several studies have examined possible markers related
to acute HAA exposure in humans after the intake of
roasted, fried, or grilled beef, chicken, and/or fish, focusing
on the analysis of both free and conjugated HAAs in urine.
The most investigated compounds so far are PhIP and
MeIQx, which have been quantified before and after en-
zymatic hydrolysis [121, 125–127] and as their phase I and
II metabolites [128–130] (Additional file 2: Table S3).
These studies show that PhIP and MeIQx are mainly trans-
formed through hydroxylation followed by conjugation,
with glucuronidation as the major urinary excretion path-
way in humans. The biotransformation products are com-
pletely excreted within 24 h after single intakes of roasted
meat [128, 130]. After volunteers had consumed identical
amounts of charbroiled beef for four consecutive days, the
excretion of PhIP in enzymatically hydrolyzed urine de-
creased almost to baseline levels 48–72 h later, with a sig-
nificant correlation between the urinary levels of PhIP and
the amount of charbroiled meat consumed [125].
The levels of MeIQx in hydrolyzed urine were higher
than those of PhIP [121, 126], suggesting a higher degree
of direct conjugation of MeIQx, or a relatively greater ex-
cretion of metabolized PhIP through feces, as shown by
Vanhaecke et al. [131]. When urine was not hydrolyzed,
only PhIP was detected in urine after the intake of a single
meal of roasted chicken, whereas unconjugated MeIQx
and 4,8-DiMeIQx, which were found in the fried chicken,
remained undetected [132]. Although the amounts of
HAA metabolites measured in urine were highly associ-
ated with the ingested dose of MeIQx and PhIP, high in-
ter- [116, 133] and intra-individual [128] variability in
metabolism of the HAAs was observed. Notably, differ-
ences between “fast” and “slow” excretors as well as be-
tween men and women were observed [128, 130].
In observational studies, MeIQx has been found to be a
more reliable urinary marker to assess consumption of highly
cooked or processed meat. The urinary levels of MeIQx [134]
and PhIP [135] have been compared among black, Asian
(Chinese or Japanese), and white men, and correlated with the
results of a food frequency questionnaire. MeIQx levels were
positively associated with the intake frequency of bacon, pork/
ham, and sausage/luncheon meats [134] while urinary PhIP
was not associated with intake frequencies of any cooked
meat, suggesting that self-administered dietary questionnaires
may not properly describe cooked meat preferences, frequency
of intake, and cooking methods [135], or alternatively that un-
known sources of PhIP affect total excretion.
Further markers related with dietary HAA exposure are
the PhIP hydroxylation metabolites. 4′-OH-PhIP (2-amino-
1-methyl-6-(4′-hydroxyphenyl)imidazo[4,5-b]pyridine) has
been proposed as detoxification product, derived from the
oxidation by several CYPs of the aromatic ring system. The
metabolite, 5-OH-PhIP (2-amino-1-methyl-6-(5-hydroxy)-
phenylimidazo[4,5-b]pyridine), has been suggested as a
marker of activation of PhIP [136] since it represents a rear-
ranged product of N-hydroxylation of the exocyclic amino
group by cytochrome P450 (CYP1A2). In several studies
[121, 132, 137], 4′-OH-PhIP was found to be the most abun-
dant urinary hydroxylated metabolite after the consumption
of cooked chicken. This compound is already abundantly
present in the heated chicken meat and only a small amount
(11% after enzymatic hydrolysis and 0.66–1.3% in untreated
urine samples) is derived from human PhIP metabolism
[132, 137]. This suggests that 4′-OH-PhIP may represent a
good marker for heated meat intake, although studies show-
ing its presence and kinetics of formation in other meats
than chicken are needed in order to validate its plausibility as
a general marker of any fried or grilled meat.
High inter-individual differences were observed for fecal ex-
cretion with no differences in the percentage of the PhIP dose
excreted [131]. Vanhaecke et al. [131] examined the urinary
and fecal excretion in humans of a newly identified microbial
PhIP metabolite, PhIP-M1 (7-hydroxy-5-methyl-3-phenyl-6,7,
8,9-tetrahydropyrido[3′,2′:4,5]imidazo[1,2-a]pyrimidin-5-ium
chloride) after the consumption of cooked chicken, contain-
ing a known amount of PhIP. Urinary PhIP-M1 increased
over time with a peak between 48 and 72 h, showing that mi-
crobial metabolism appears later in the excretion profile of
Cuparencu et al. Genes & Nutrition           (2019) 14:35 Page 10 of 30
body fluids compared to the parent compound. The percent-
age of recovered PhIP-M1 was quite high in feces, with high
variability among subjects, probably associated with differ-
ences in diet, digestion, metabolism, and microbial compos-
ition. There was no difference in the percentage of the PhIP
dose excreted as PhIP-M1, indicating apparent dose-
response. In conclusion, this additional microbial PhIP me-
tabolite, PhIP-M1, adds to the complex metabolism of PhIP
and may further complicate the use of any PhIP metabolite
for monitoring exposures to heated meats.
Other compounds besides PhIP and MeIQx have
been identified in urine after the intake of roasted meat
(Additional file 2: Table S3). These include 9H-pyrido[3,
4-b]indole (norharman) [132, 138], IQ (2-Amino-3-
methylimidazo[4,5-f]quinoline), Trp-P-2 (3-amino-1-
methyl-5H-pyrido[3,4-b]indole), Trp-P-1 (3-amino-1,
4-dimethyl-5H-pyrido[3,4-b]indole), and AαC (2-
amino-9H-pyrido[2,3-b]indole) and harman [138].
However, these molecules were found to be less reliable as
markers of exposure to heated meat, when compared to
PhIP and MeIQx. Their presence in body fluids or tissue
may not be entirely due to meat consumption, but also to
smoking habits [139–141], endogenous production, and
the consumption of other foods derived from heating or
fermentation, such as alcoholic drinks and coffee [142].
Markers related to the intake of high-intensity cooked
meat have been investigated also in human hair, providing
an average of the exposure over a period of several months
[143–150]. Analysis of hair samples showing dose-
response, a known dependence on melanin levels and inde-
pendence of hair dying, and CYP1A2 phenotype, has been
shown for measurement of PhIP after fried beef intake for
3–4 weeks [143–145]. The lack of dependence on metabol-
ism is in accordance with findings showing that CYP1A2
phenotype over a 20-fold activity span is a poor predictor
of HAA metabolite excretion in urine [150]. Turesky et al.
[149] examined the levels of PhIP accumulating in the hair
closest to the scalp of 44 volunteers after a 4-week semi-
controlled diet of cooked meat containing known quantities
of PhIP. The study showed a good correlation between the
level of PhIP in hair and the dose of PhIP ingested. Kobaya-
shi et al. [144] compared PhIP levels in the hair of seven
volunteers with the results from dietary records over 28
consecutive days. PhIP levels in hair were found to be
highly associated with the grilled/stir-fried meat intake but
not with the grilled/stir-fried fish intake. The marker, there-
fore, seems to be useful in very different populations in
terms of food culture and genetics. No other HAAs can be
measured in hair and no, or only marginal, PhIP could be
measured in vegetarians. These studies point to PhIP in
hair as a promising biomarker for assessment of average in-
takes of heated terrestrial meats but further validation stud-
ies are needed to assess stability of the samples and
influence of hair structures.
In conclusion, the studies reported so far identified
and quantified specific carcinogenic HAAs in urine,
feces, and hair after consumption of well-done, heated
meat, showing that there is a significant correlation be-
tween the intake and the excretion of these compounds.
In particular, the most promising exposure markers
seem to be total PhIP and MeIQx in urine and PhIP in
hair. The complexity of absorption, metabolism, and dis-
tribution of these compounds leads to very high inter-
and intra-individual variation for some of the blood and
urine metabolites and these compounds may therefore
only work reliably as markers for comparison of groups
rather than individuals. PhIP in hair seems a consistent
candidate biomarker to estimate intakes of fried or
grilled terrestrial meat.
Polycyclic aromatic hydrocarbons
PAHs are mainly produced from the incomplete combus-
tion of organic matter. Therefore, the main human expos-
ure sources are associated with environmental factors, such
as tobacco smokes, emission of vehicles, and occupational
exposure [151]. Anyway, it has been observed that in non-
smoking subjects without occupational exposure, the main
source of PAHs is represented by food [152, 153]. PAHs
are present both in uncooked and cooked food. In the
former, these compounds may originate from environmen-
tal contamination from soil, air, or water [154]. Cooked
food, particularly meat grilled directly over an open flame,
grilled over charcoal, or smoked, may contain measurable
amounts of PAHs arising from fat pyrolysis or from the ad-
sorption onto foods of PAHs emitted from the combustion
process [155]. The most abundant PAHs reported in barbe-
qued or grilled meat were naphthalene (NAP), phenan-
threne (PHE), fluorine, and pyrene [152, 156].
Urinary 1-hydroxypyrene (1-OHP) and 1-hydroxypyrene-
O-glucuronide (1-OHPG), two metabolites of pyrene, are
considered the most relevant biomarkers for assessing indi-
vidual exposure to PAHs [157–160]. Even though they have
been observed to increase following the consumption of bar-
becued meat, a very high inter-individual variability has been
observed, suggesting that these metabolites may not be suit-
able markers for individual assessment of the intakes of
grilled, broiled, or roasted meat [158–160]. Furthermore, it
has been reported that the main source of urinary 1-OHPG is
cigarette smoke, while car vehicle exhaust contributed almost
to the same extent as the diet in non-smoking subjects [161].
A considerable amount of 1-OHPG excretion is also attrib-
uted in populations using mate tea while fried or grilled meat
was not significantly associated with 1-OHPG [162]. Cooking
methods (baking bread at home and the intensity of food fry-
ing), passive smoking, and genetic polymorphisms affecting
hydroxylation and conjugation, additionally highly contrib-
uted to the excretion of 1-OHPG [163]. Therefore, the back-
ground levels for 1-OHPG would be too variable in a real
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exposure setting and the contribution of dietary intake of
high-intensity heated meat could not be distinguished from
environmental factors, even in subjects who never smoked.
Further studies identified monohydroxylated metabolites
of NAP and PHE in urine as possible markers of short-
term dietary intake of PAHs after consumption of fried beef
and chicken, particularly 2-hydroxy-NAP and 1-, 2-, 3-, 4-,
and 9-hydroxy-PHE [152, 156]. These metabolites demon-
strated a high correlation with the parent compound
present in food in a highly controlled setting where the en-
vironmental confounders were minimized. Even though
these metabolites show a higher robustness in relation to
the other environmental factors, the existence of other
background source acting as potential confounders cannot
be overruled. NAP and PHE are well-known environmental
contaminants causing aquatic toxicity and they are there-
fore likely to show environmental bias similar to other
PAH related markers [164].
In conclusion, none of the markers of PAH intake are cur-
rently promising markers of charcoal-grilled meat intake.
Processed meat
The search for papers on processed (not including heat
processing) meat biomarkers delivered 2522 papers via
PubMed and 2560 papers from Web of Science. This ren-
dered 3772 unique papers, of which 38 were included after
screening of the titles and abstracts, whereas only six rele-
vant papers remained after assessment of the full text. Ex-
clusion was based on a lack of focus on the assessment of
dietary intake in general, and processed meat intake in par-
ticular. Four additional papers were retrieved after the sec-
ondary web search. In total, 12 relevant papers were found,
reporting putative markers such as MeIQx, 1-OHP, thio-
barbituric acid reactive substances (TBARS), ATNCs, nitro-
soproline, glycerophosphatidylcholine (PC) C38:4 (PC38:4),
acetylcarnitine, carnitine, and lathosterol. Out of these,
MeIQx and 1-OHP are also markers of grilled and fried
meat; ATCN and DHN-MA are potential markers of
heme-containing foods; carnitine and acyl-carnitines are
candidate markers of meat intake in general; and lathos-
terol, TBARS, and PC38:4 are unspecific to processed meat
intake. These compounds were therefore disregarded as
candidate markers of processed meat. However, they may
still be useful as part of combined markers for processed
meat intake assessment. This leaves N-nitrosoproline as the
only candidate biomarker for this specific meat subgroup.
N-nitrosoproline
Decades ago, Stich and co-workers [165] investigated the
interfering role of the consumption of nitrite-preserved
meats on urinary N-nitrosoproline concentrations. The re-
sults demonstrated that N-nitrosoproline increased signifi-
cantly after the consumption of, e.g., tinned ham, pork
luncheon meat, and different types of sausages, although
N-nitrosoproline can also be formed endogenously in the
gastro-intestinal tract. The authors were able to directly link
N-nitrosoproline levels in different processed meat types to
higher levels of N-nitrosoproline in human urine. Moreover,
endogenous N-nitrosoproline formation appeared to be negli-
gible in comparison with the levels formed after intake of
cured meats. N-nitrosoproline therefore demonstrated poten-
tial to serve as a candidate quantitative biomarker for the in-
take of nitrite-preserved meat. Later on, other investigations
showed that nitrite-preserved meat is not the sole or even the
main potential contributor to elevated urinary N-
nitrosoproline [166, 167] since tobacco use is another import-
ant source, eliminating N-nitrosoproline as a robust, specific
biomarker for nitrite-preserved meat intake. However, other
sources may be identified with other biomarkers and combi-
nations of markers may therefore be developed to assess in-
take of cured meat besides other environmental or food
sources. Further studies of N-nitrosoproline in complex ex-
posure scenarios are therefore warranted.
Unidentified potential markers of processed meats
In studies by Playdon et al. (2016) and Cheung et al. (2017),
the occurrence of five unidentified compounds was associ-
ated with the intake of processed meat [38, 62]. Additional
research is required to identify these molecules and assess
their relevance as markers of processed meat intake.
In conclusion, only a limited amount of original re-
search papers document the search for a processed meat
biomarker. More importantly, up until now, none were
able to identify a biomarker that is specific for processed
meat intake.
Biomarkers of fish, fish oil, and other seafood intake
Three parallel searches of the scientific literature have
been carried out for markers of aquatic meats and oils:
one search addressed the identification of markers re-
lated to fish and fish oil intake, another on seafood, and
a third search was focused on naturally occurring envir-
onmental toxicants related to seafood consumption
(Additional file 1: Table S2).
A number of 1340 unique articles were identified for the
search on fish and fish oil biomarkers of which 1115 articles
were discarded in the first screening based on title and ab-
stract. The main reasons for exclusion were effects on physi-
ology, bone health and calcium metabolism, macular
degeneration, effects on drug metabolism, as well as studies
on effects in fish. Out of the 225 papers included in the sec-
ond screening for which the full-text was assessed, 55 were
kept and are included in Additional file 2: Table S3 together
with 19 papers identified from the secondary searches. Pa-
pers that were discarded dealt with irrelevant diets (pure n-3
fatty acids, not fish oil), arachidonic acids, seal, astaxanthin
from microbes, etc.), outcomes (effects on cholesterol levels,
1-carbon metabolism, immunology, fatty acid levels in breast
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milk, neurological development of newborns, urinary iodine
excretion), or were excluded due to poorly reported method-
ology or inappropriate study designs for BFI discovery. One
proteomics study unrelated to biomarker discovery and four
studies for which the access links were unavailable were also
excluded. Several additional studies arose from the literature
search within the general meat section, while one cross-
sectional and one intervention study were found through the
targeted searches on TMAO and CMPF (3-carboxy-4-me-
thyl-5-propyl-2-furanpropionic acid), adding a total of 15 pa-
pers to the final list (n = 86). Among the papers included in
Additional file 2: Table S3, 45 are relevant for fish consump-
tion, 34 for fish oil supplementation, and five investigate both
fish and fish oil mixed intakes.
The literature search for shellfish resulted in 443 pa-
pers, of which 33 were kept after screening abstracts and
titles. The reasons for exclusion were investigation of
contaminants in seafood and their effects on health, ef-
fects on physiology of aquatic food consumption, and
food allergies. After accurate examination of the text,
the remaining papers included 19 mentioning shellfish,
13 on mixed intakes together with fish, and six only on
shellfish, see Additional file 1: Figure S1.
For the search on natural environmental contaminants
associated with the intake of aquatic meats, only arseno-
compounds have been considered. The literature search
resulted in 100 papers, which were reduced to 14 after
screening abstracts and titles. Generic markers for inor-
ganic arsenic exposure were excluded. Other reasons for
exclusion within this category were irrelevant dietary
intervention (e.g., arseno-sugar and cod liver) and a lack
of firm conclusions in associating specific foods to the
markers of interest. Only eight papers measuring organo-
arsenic species in body fluids and tissues in relation to
fish, mixed fish, or shellfish intakes were included and
these papers are therefore listed under the fish, or mixed
fish and shellfish categories.
In Additional file 2: Table S3, the studies on intake
biomarkers of fish, fish oil, shellfish, and mixed expo-
sures of these are listed in separate sections; however,
due to the large overlap in the compounds identified as
markers, the foods are all discussed under one heading
here and subdivided by chemical class.
Several biomarkers have been found to be associated with
intake of fish and shellfish as reported in Additional file 2:
Table S3. The majority of the studies concern consumption
of marine foods and derived products aimed to increase the
levels of omega-3 (n-3) long-chain polyunsaturated fatty
acids (n-3 LCPUFAs) in biofluids and tissues, while more re-
cently suggested markers include furan fatty acids, e.g.,
CMPF, TMAO, 1,2,3,4-tetrahydro-β-carboline-3-carboxylic
acid (THCC), cetoleic acid, astaxanthin, and organoarsenic
compounds, such as arsenobetaine. Fish and shellfish are rea-
sonably high in the trophic chain and tend to accumulate
compounds present in their local pray or foods. This accu-
mulation depends on the biotope, e.g., marine or fresh wa-
ters, geographical differences, and also on the fat content of
the fish or shellfish. A high abundance of LCPUFAs, in-
cluding docosahexaenoic acid (DHA), exists in marine
plankton [168] while freshwater microalgae are generally
forming other fats and only little eicosapentaenoic acid
(EPA) [169]. Most fatty acids and xanthophylls are depos-
ited in fats and accumulate more in fatty fish while
TMAO is produced in some species to regulate osmotic
pressure in deeper marine waters. Biomarkers of fish and
shellfish may therefore depend on the local environments
where these foods come from.
n-3 LCPUFAs
The n-3 LCPUFAs, EPA and DHA, as well as their inter-
mediate product, docosapentaenoic acid (DPA), are high in
marine fatty fish and in cod liver. Two to 20 times lower
levels are found in most other aquatic meats, including
shellfish, lean fish, some freshwater fish, and farmed fish
from coastal waters or ponds, while terrestrial meat are 20–
100 times lower, depending on their feed [170]. The n-3
LCPUFAs in blood are well-established fish-related bio-
markers, known for their high specificity to fish and shell-
fish. In particular, fatty fish such as salmon, tuna, herring,
and mackerel are affecting blood n-3 LCPUFAs [171]. Al-
though eggs and meats originating from livestock fed with
diets high in n-3 may also provide some quantities of EPA
and DHA (e.g., through their higher consumption rates in
many populations), marine and freshwater foods represent
by far the main dietary source of n-3 LCPUFAs [171, 172].
LCPUFAs can additionally be synthesized in humans by
converting α-linolenic acid (ALA) through a well-
documented series of elongations and desaturations [173].
However, the conversion rate of ALA from plant sources is
limited [174] and should therefore not interfere with the
net content provided by marine sources.
EPA and DHA have often been used to assess compliance
to fish and fish oil intake in intervention studies [175–179],
and have been extensively associated with self-reported fish
intake, measured either through 24-h dietary recalls or
FFQs in a wide range of cohort and cross-sectional studies
carried out in different populations [45, 180–183]. Further-
more, EPA and DHA have been widely used to validate
proposed FFQs for assessment of fish intake [83, 184–187].
DHA, DPA, and EPA were also shown to increase in a 12w
parallel RCT in adolescents comparing fish meals (herring,
salmon, mackerel) with meat (chicken, turkey, beef, lamb)
and cheese [188].
Blood is the most extensively explored matrix for
measuring PUFAs; however, blood components differ in
their metabolism and incorporation of LCPUFAs [189],
thereby greatly influencing the duration of consumption
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reflected and the selection of the adequate blood fraction
to match the intended outcome.
Plasma and serum have been suggested to reflect shorter-
term intakes, whereas erythrocyte membranes and adipose
tissue are more reflective of long-term (habitual) consump-
tion of fish [190]. In serum, EPA, DHA, and total n-3 fatty
acids increase within 4 h after intake [191], whereas their
levels in cholesteryl esters (CE) and red blood cells (RBC)
were only apparent after 3 days of supplementation. Incorp-
oration of EPA and DHA was also shown in PC after 1–2
weeks, whereas levels in platelets were affected after 3–4
weeks and 1–2 months, respectively [192]. The incorpor-
ation of DHA was further reported to be slower than that
of EPA in CE, RBC membranes, and the adipose tissue of
healthy adults [193].
Plasma phospholipids act as transporters and are there-
fore a more transient compartment than RBC membranes
[190, 194], with equilibrium reached after 1 and 6 months,
respectively, at fixed dietary intakes [195]. The clearance
of EPA and DHA from plasma phospholipids was also
shown to occur more rapidly than from RBC [196], em-
phasizing on the ability of plasma phospholipids to ad-
equately reflect only short-term changes in intake (weeks).
Esterified LCPUFAs in whole blood were associated as
strongly as LCPUFAs in erythrocytes in a fish oil interven-
tion with 0.25–1 g/day of EPA and DHA over 4 weeks
[197], and were shown to have similar kinetics within
RBCs and in plasma, while EPA has faster kinetics than
DHA [198]. The sum of EPA + DHA in plasma PCs was
suggested as a suitable biomarker for recent EPA + DHA in-
take, while platelet and mononuclear cell EPA + DHA may
reflect habitual intakes, showing reasonable dose-response
relationship [192]. PC-EPA was also reported in an untar-
geted metabolomics investigation with fish oil [199] as well
as in a cross-sectional association with aquatic meats [200],
both measured in serum. Fish studies targeting PC-EPA and
PC-EPA + PC-DHA may thus potentially shed light upon
more accurate assessment of short-term fish intake.
Adipose tissue is less sensitive to changes in dietary n-
3 PUFA than other lipid pools, thus fatty acids content
in adipose tissue reflects only longer-term intake of fish
oil [193, 201].
In studies where similar content of EPA and DHA was
provided as either fish oil capsules or fatty fish, differen-
tiation by plasma markers between these intakes is not
possible [189, 202], nor is it possible to reflect different
composition of the fish and fish oil [203].
Only one intervention study investigated the potential
dose-response relationship between LCPUFAs after fish con-
sumption [204]. EPA measured in plasma phospholipids
showed dose-response at doses of 180 g and 270 g of salmon
consumed twice a week for 4 weeks, but no significant differ-
ence from control was observed at 90 g of salmon. In con-
trast, DHA seemed to reach a plateau in this study even after
90 g salmon consumed, without a subsequent increase at
higher doses [204]. When added together, EPA + DHA
showed a dose-response starting with the lowest level of fish
intake [204]. Other studies that investigated dose-response
only used fish oils. In blood samples, EPA and DHA dis-
played dose-response in some studies with fish oil [193,
205–207, 209, 210]. Ulven and colleagues compared the effi-
cacy of fish or krill (Euphausia superba, a crustacean) oils on
n-3 LCPUFA contents in fasting plasma samples of healthy
volunteers. Despite lower n-3 contents in krill oil, effects
comparable to fish oil were observed for EPA, DPA, and
DHA, suggesting that bioavailability of n-3 PUFA from krill
oil is equal or even more efficient than that of fish oil [211].
The different efficiency may be attributed to different
n-3 containing fats in krill oil, mainly phospholipids,
compared with fish oil, mainly triglycerides. In a 14-day
dose-response study, Hudson et al. have shown that in-
corporation of EPA, DPA, and DHA in PC shows dose-
response in the range from 0.3–4.5 g EPA + DHA/day
so that contents in PC is a sensitive and dynamic meas-
ure of recent LCPUFA intakes [212].
The use of DHA and EPA as BFIs for fish are likely to re-
flect mainly marine fish and should therefore be validated
separately for different populations, as always recommended
for BFIs [24]. In experimental studies, lean fish only affect n-
3 LCPUFAs to a very limited extent [213] while these
markers in observational studies have less power to discrim-
inate lean and fatty fish intakes [180, 214–216]. Shellfish have
a composition similar to lean fish but most observational
studies on EPA and DHA did not differentiate between fish
and other shellfish [184, 216, 217]. When shellfish intake was
evaluated separately from non-fried fish intake in 900 partici-
pants from the Multi-Ethnic Study of Atherosclerosis
(MESA), no association was observed between the concen-
trations of EPA and DHA in plasma phospholipids and shell-
fish intake [218]. When looking into intakes of more specific
shellfish such as oysters, clams, crabs, squid, mussels, and
shrimp in normolipidemic men, all shellfish increased n-3
PUFAs in fasting plasma and erythrocytes, except for clams
that only elevated them in plasma, and shrimps that only
showed an effect on RBC [219]. The plasma levels increased
five times more than those in RBC, confirming that the turn-
over rate in different compartments is affected similarly by
fish and shellfish. Tropical shellfish, unlike those from tem-
perate waters, are a source of both n-3 and n-6 PUFAs, as
shown by increased plasma levels of arachidonic acid re-
ported together with the regular EPA, DPA, and DHA [220];
this underlines once again that BFIs should always be vali-
dated for each specific population taking their food sources
into consideration.
Ratios of n-3/n-6 fatty acids
Fish intake negatively affects the plasma levels of certain
omega-6 PUFAs. Linoleic acid (LA), gamma-linolenic
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acid (GLA), dihomogammalinolenic acid (DGLA), and
arachidonic acid (AA), all n-6 PUFAs, have often been
reported in studies on fish intake, but are of limited
interest as fish intake biomarkers since they do not re-
flect fish intake per se but rather a change in their equi-
librium with the n-3 FAs. Consequently, FA ratios such
as n-3/n-6, n-6/n-3, the omega-3 index, and EPA/AA
may be of potential relevance for health outcomes re-
lated to fish consumption, but are not robust as BFIs, as
they are highly influenced by other food sources, al-
though they may be relevant in some specific studies
[204, 214, 221–224]. The same applies to the reported
sum of n-3 and sum of n-6 PUFAs, measured in a hand-
ful of studies reported in Additional file 2: Table S3
[176, 191, 201, 204, 213, 214, 225–233], as they can easily
be affected by the intake of other food groups than aquatic
or terrestrial meat, such as vegetable oils and nuts.
In conclusion, n-3 LCPUFA in different blood com-
partments seem to be valid biomarkers of fatty fish in-
take and also of total fish, fish oil, and shellfish intake in
populations consuming a mixed diet. The ratios, EPA/
AA, (EPA + DHA)/AA, and (n-6)/LCPUFA may only be
useful in controlled studies comparing fish and meat
since they are too sensitive to other n-6 FA sources to
be useful as general fish intake biomarkers.
Furan fatty acids
In addition to DHA and EPA, furan fatty acids have
been recently suggested as biomarkers for fish/fish oil
intake. CMPF was identified as a biomarker for fish con-
sumption in fasting plasma, as its level was associated
with dietary fish intake after a 12-week intervention trial
with a Nordic diet [234]. In addition, another dietary
intervention study has reported increased furan fatty
acids after increased protein intake from fish and meat,
including circulating levels of CMPF following consump-
tion of a Mediterranean-type diet [235]. Plasma, serum,
and urine CMPF has been observed also in free living
populations across the Northern Hemisphere, where
levels were associated with habitual dietary intake of fish
and shellfish in several populations in Europe, China,
and the USA [62, 236, 237]. Plasma as well as urine
CMPF has also been observed to increase in hyperlipid-
emic patients after 600 mg/day of fish oil for 4 weeks
and levels were still increased after 4 weeks’ wash-out
[238]. Besides CMPF, four other compounds putatively
identified as furan fatty acid metabolites were increased
in blood after a diet high in fish [235, 239].
Trimethylamine-N-oxide
TMAO is a naturally occurring metabolite abundant in
certain fish or generated from nutritional compounds in-
cluding choline and carnitine by a microbiota mediated
conversion of betaines to trimethylamine and further
oxidation by hepatic flavin monooxygenases to TMAO
[240, 241]. Several studies have shown increased urinary
excretion of TMAO related to consumption of fish: a
high level of TMAO in morning urine was associated
with intake of fish containing PUFA and n-3 PUFA on
the previous day [242]. Increased urinary TMAO was
also observed within 4.5 h after a salmon-containing
breakfast [47]. In an intervention with fish or meat
dishes, urinary TMAO increased substantially after fish
intake but not after standardized meals containing
chicken, red meat, or processed meat [38]. In another
crossover meal study with three fish dishes, three meat
dishes and three lacto-ovo vegetarian dishes, TMAO in-
creased in urine only after fish intake, peaking at 3 h
[93]. TMAO in urine seems to show good specificity as
a potential biomarker of fish and shellfish intake, be-
cause only fish and other aquatic meat products contrib-
uted to elevated urinary excretion of trimethylamine and
TMAO, among 46 investigated food groups [240].
TMAO levels in plasma showed a dose-response with
increased intakes [38], but also increased postprandially
after intake of a fish meal, thus proving that the TMAO
present in fish can be readily absorbed without the in-
volvement of gut microbiota, while TMAO is elevated
much later when metabolic precursors in meat are con-
verted to TMAO by the gut-host co-metabolism [94].
TMAO is particularly high in sharks, skates, cods, and
other fish diving in temperate or cold sea waters, serving
as a muscle osmolyte, and it is also found in crustaceans
from the same biotopes [243]. It may therefore be a bet-
ter biomarker for intake of this group of fish and shell-
fish, e.g., from the North Atlantic Ocean. Plasma TMAO
has recently evoked attention as potential risk factor for
cardiovascular diseases [244]. However, this risk seems
to be partially related to reduced kidney function [245]
and also depends on the composition of the gut micro-
biota [94]. Therefore, the potential implication of
TMAO from aquatic meat in disease development still
needs scrutiny. In conclusion, TMAO in urine is a can-
didate short-term biomarker of intake for fish and shell-
fish from deeper water layers, at least in the North
Atlantic Ocean, while studies of fish and shellfish from
most other biotopes are still missing.
1,2,3,4-Tetrahydro-β-carboline-3-carboxylic acid
In a randomized, single-blinded, crossover meal trial,
metabolomics analysis was used to investigate plasma and
urinary excretion following consumption of cod protein
compared to other protein sources, such as whey, casein,
or gluten. The tryptophan-derivative THCC was elevated
in plasma and urine after cod protein intake [95]. Further
studies to evaluate its specificity are needed, given the po-
tential presence of THCC at considerable levels in cocoa
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products and in some fruit juices, jams, and fermented
food products [246]. THCC is therefore not considered
further as a fish intake biomarker.
Amino acids
Increased urinary excretion of taurine and 3-methylhistidine
have been observed after fish and shellfish intake but have
also been associated with animal protein consumption [247].
Though being less specific than TMAO, plasma levels of tau-
rine, methylhistidines, and N6,N6,N6-trimethyl-lysine were
also elevated following the consumption of cod protein [95].
Anserine, 1- and 3-methylhistidine were also reported in
urine after a smoked salmon-containing breakfast [47]. As
methylhistidines and taurine may be derived from several
different sources of animal muscle, they are not specific to
fish or shellfish and have therefore been discussed in the sec-
tion on general markers of meat intake. However, in com-
bined biomarker approaches, they may serve to distinguish
between intake of fish (as part of “white meat”) from intake
of mammalian red meats but this approach will need add-
itional study.
Other lipids
Other lipids have been suggested as possible biomarkers
of fish intake. In particular, a lipidomics investigation
from O’Gorman et al. [248] demonstrated that a com-
bination of specific lipid patterns had a reasonably good
ability to discriminate between low and high dietary fish
intake (AUC = 0.76) in 34 volunteers from the Metabolic
Challenge Study (MECHE), with lysophosphatidyletha-
nolamine (LPE) acyl C18:2 (LPE (18:2)) and phosphati-
dylethanolamine diacyl C38:4 (PE (C38:4)) identified as
potential biomarkers in serum. Since C18:2 (LA) is an
(n-6) fatty acids unrelated to fish intake, the association
may be caused by confounding with, e.g., oils used for
frying the fish. In another randomized controlled trial, a
fatty fish-based diet produced an increase in the levels of
lysoPC (20:5) and LPEs (20:5) and (20:6), which are very
likely derived directly from the fatty fish [234]. Plasma
phospholipid-LCPUFAs may serve as BFIs for shorter
term or recent fatty fish intake in analogy with free
LCPUFAs as already discussed.
In a study on plasma lipids in overweight men following
meals with baked herring or baked beef, cetoleic acid (22:
1) increased after herring intake, while 2-aminoadipic acid,
leucine, β-alanine, and 4-hydroxyproline reflected beef in-
take [57]. Additional studies of cetoleic acid as potentially
specific to intake of herring or of fish in general is needed
for confirmation.
Astaxanthin
Astaxanthin is a natural lipophilic compound, which be-
longs to the xanthophylls and its bioavailability is en-
hanced by dietary lipids [249]. While it is found in a
variety of aquatic organisms, including algae, krill, crayfish,
salmon, salmon roe, shrimp, and crab, particularly high
amounts are found in the flesh of salmon and in the cara-
pace of crustaceans [250, 251]. No studies exist to evaluate
the main food sources of plasma astaxanthin in different
populations but in the Western World, salmon and shell-
fish are likely to be the major sources. Astaxanthin cannot
be synthesized by animals or humans, but it is essential
for the growth of Atlantic salmon alevins [252] and its
presence therefore indicates accumulation from food.
Astaxanthin isomers, preferentially absorbed and concen-
trated into VLDL in humans, contain cis-double bonds,
whereas the all-trans astaxanthin is most accumulated in
salmonoids [253, 254]. The biokinetics of astaxanthin have
only been studied after supplementation. The maximal
concentration of astaxanthin in serum is found at 12 h
reaching Cmax of 50–280 μg/L after intake of doses of 10–
100 mg given as supplements and is then declining with a
half-life of around 12–21 h [253–255]. Accumulation of
astaxanthin has been indicated from doses of 1–3 mg over
4–12 weeks showing dose- and time-dependent increases
up to final levels of 11 μg/L after 1 mg/day and 35 μg/L
after 3 mg/day at 12 weeks [256]. Daily doses of 4 mg
astaxanthin over 3 months were found to provide final
plasma levels of around 30 μg/L in reasonable agreement
with other data [257]. Feeding of hens with algae, specific
yeasts, shellfish waste, or even synthetic astaxanthin has
been shown to increase its presence in egg yolk, providing
the basis for commercial “golden” eggs [258]. Other food
sources in the human diet besides supplements are food
colorants, e.g., E161. However, they are likely to be
minor in populations ingesting aquatic meats. Back-
ground levels, presumably from aquatic meat intake, in
middle-aged Japanese males were found to be 0.1–0.5
μg/L while background levels in Norwegian, German,
or Dutch men and in Korean women were reported as
non-detectable [254, 256, 259–261]. In groups of Eng-
lish and Russian subjects abstaining from aquatic meat
for 10 days, levels were 0.25 μg/L [262]. In a study with
28 German men, recruited to consume 250 g wild or
aqua-cultured salmon providing 5 μg astaxanthin/g sal-
mon flesh in a randomized and double-blind trial over
4 weeks, plasma astaxanthin concentrations of around
25 μg/L were detected [261]. The bioavailability from
salmon seems therefore comparable to or higher than
what was observed with the supplements.
In conclusion, astaxanthin may not be specific to fish
and shellfish but in populations with low intakes of other
sources of astaxanthin, it can be considered a candidate
biomarker of these foods. Since there is good concordance
between plasma levels measured in different laboratories,
astaxanthin is likely to have good reproducibility. How-
ever, inter-individual response to the same dose of astax-
anthin was quite large in some of the studies [256, 261].
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Organoarsenic compounds
It has been observed that many persistent organic pollut-
ants (e.g., dioxin and organochlorine pesticides) and inor-
ganic pollutants (e.g., mercury) are highly associated with
fish consumption [263]. However, the presence of such
compounds and elements in several other food matrices,
as well as their differential distribution worldwide, create
highly variable background levels, which do not allow the
use of such compounds or their metabolites as reliable fish
intake biomarkers [264]. Thus, for the search on environ-
mental contaminants associated with the intake of aquatic
meat, only arseno-compounds have been considered,
given their high specificity to marine foods.
Due to the bioaccumulation of arseno-compounds along
the aquatic food chain, fish and shellfish contain significant
amounts of arsenic (As). In marine organisms, inorganic As
present in ocean water is transformed into unique organic
compounds by methylation or esterification with sugar
(arsenosugars), lipid (arsenolipids), betaine (arsenobetaine,
AsB), or choline (arsenocholine) [265]. AsB and methylated
As (dimethylarsinate or DMAs, monomethylarsonate or
MMAs) constitute the biggest proportion of As in fish and
shellfish, while inorganic As(III) and As(V) are the least
abundant metabolites [266]. Urinary profiles of As metabo-
lites thus showed a positive dose-response relationship with
recent fish or shellfish intake, despite differences based on
species [267] and preparation method, since the water-
soluble As metabolites are easily leaking from the meat
when boiled [268].
Urinary excretion of DMAs 13–24 h after aquatic
meat intake [266, 269] shows that As methylation is one
of the As detoxification pathways in the human body
[267, 268]. Urinary level of DMAs can thus also reflect
As exposure from any other sources, such as seaweed
[270], rice, mushroom [271], drinking water [269], or in-
halation [272]. Consequently, DMAs and MMAs have
low specificity as potential biomarkers of fish intake and
are not considered further here.
Another major As metabolite, AsB, was rapidly ex-
creted after fish and shellfish intake [95, 266, 268], show-
ing limited biotransformation and accumulation.
Formation of AsB from other As metabolites takes place
in humans and AsB also influences urinary DMAs excre-
tion [267, 269]. The extent of these processes may be
limited since AsB was not associated with As content in
drinking water [269] or inhaled air [272], and was only
weakly associated with rice intake [269]. In addition,
urinary AsB is less susceptible to inter-individual vari-
ation than other organoarsenic species, especially when
expressed as concentration rather than as μg/g creatin-
ine [266]. Adjustment for AsB or stratified analysis in
some subjects with undetectable urinary AsB nullified
the association between aquatic meat intake and urinary
concentrations of total As or DMAs [270]. This finding
supports the specificity of AsB as a biomarker of total
fish and shellfish intake and AsB seems to be a promis-
ing candidate biomarker for these foods.
The most commonly investigated biospecimen for AsB
quantification is urine [266, 269, 270]. We only found
one intervention study by Stanstrup and colleagues [95]
that examined the biomarkers of acute fish intake in
both plasma and urine samples, however without com-
paring the performance of the two. We did not find any
article discussing the measurement of plasma AsB as a
potential indicator of habitual fish intake. Hence, current
evidence support the usage of plasma AsB to reflect only
recent intakes, and urinary AsB as an indicator of both
recent (within 3 days) [269] and habitual fish and shell-
fish intake [270]. The kinetics of AsB varied across inter-
vention studies, peaking in plasma within 4–14 h and
returning to baseline after 8–50 h for intakes of cod [95,
267] and for urinary excretion after intake of crabs, wolf-
ish, and lemon soles [272]. An observational study
showed an association between urinary AsB and fish and
shellfish intake within the last 72 h [266]. Association
between urinary AsB and habitual aquatic meat con-
sumption in the past year [270] was also observed at the
group level but suggests no retention or tissue accumu-
lation of AsB. Furthermore, as a natural, widespread
water pollutant metabolite, AsB levels in fish or shellfish
may vary across species and location [267]. Current evi-
dence indicates that AsB may serve as a promising quali-
tative biomarker of fish and shellfish intake but its use
for quantitative purposes needs further investigation.
Studies so far were conducted in Caucasian populations
in Europe [95, 266, 267, 272] and the US [270]; studies
in other populations are therefore warranted. Other As-
compounds such as arsenolipids and arsenosugars did
not show enough potential as fish intake biomarkers be-
cause the biotransformation to larger organoarsenic me-
tabolites does not always occur in the aquatic food
chain. Moreover, in the human body, arsenosugars and
arsenolipids are metabolized by the liver to thioarsenic
[273] and As-containing fatty acids [274], respectively,
rather than to DMAs or other smaller As-metabolites
[267]. Inter-individual variability in arsenosugar metab-
olism has also been previously reported [273]. These As
compounds are therefore unlikely to be good biomarker
with specificity to fish or shellfish intake.
In conclusion, n-3 LCPUFA in blood are valid BFI for
the intake of fatty fish and fish oil at the individual level
and would therefore reflect compliance to these foods in
experimental studies, with measurements in different
blood compartments reflecting the average intakes over
different time periods. Marine lean fish and shellfish also
contribute to their levels, while the contribution from
freshwater fish depends on their feed. Total n-3 LCPUFA
in most blood compartments should therefore reflect
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overall fish and shellfish intakes in populations with mixed
diets. CMPF and related furan fatty acid metabolites in
blood or urine are not sufficiently investigated; they may
reflect more recent intakes of fish, fish oil, and shellfish
but might also reflect habitual intakes over the last 4
weeks or more, and may depend on the origins of these
foods. TMAO in urine is a shorter-term marker of intake
for certain marine fish and shellfish, especially those from
cold-temperate, deeper sea levels. Additional biomarkers
of mainly marine fish and shellfish may include arseno-
betaines in urine and possibly plasma, but further valid-
ation is needed for these markers, as well as for CMPF
and TMAO. A biomarker reflecting intake of lean fresh-
water fish has not been found in this literature review. No
specific biomarkers arose from our separate search on
shellfish.
Validation of candidate biomarkers
The literature search outlined in the previous sections
points to several putative biomarkers which may poten-
tially be used to assess intake of animal protein, meat or
fish and shellfish. However, several of these putative
markers were not considered suitable as candidate BFIs
for any of these foods. The reason for inclusion or exclu-
sion of each compound from the list of putative markers
is reported in Additional file 3: Table S4. The resulting
list of candidate biomarkers have been further evaluated
to assess their usefulness as BFIs through the eight valid-
ation criteria, previously proposed by the FoodBAll con-
sortium [24] as reported in Table 1.
All the candidate markers in Table 1 are plausible
(question 1) in the sense that their origin or presence in
the food is well known or explained and also reasonably
unique for the food group. Regarding the ability to quan-
titatively estimate the intake of a certain food, most of
the candidate BFIs seem valid at the population level;
even though a good dose-response relationship has been
reported for several of the BFIs at the individual or
group level (question 2), we still have little evidence for
exact quantitation of individual food intake in samples
from observational studies. Variation may be high due to
the high variability in the concentration of precursors in
different foods, to differences in absorption and metab-
olism, and to matrix effects caused by other dietary fac-
tors. The use of BFIs for quantitative assessment of food
intakes should therefore be carefully considered for each
specific study population, sample type, and for each spe-
cific intake assessment. For the remaining questions, the
available evidence depends on the marker and its appli-
cation as outlined below.
None of the meat exposures can be assessed quantita-
tively and without limitations by any candidate BFI. In gen-
eral, the development of meat biomarkers faces significant
challenges, such as (i) the overlap between meat-related
metabolites and products of human muscle catabolism, (ii)
variations in raw meat caused by variation between and
possibly also within species, and (iii) the influence of pro-
duction systems and feeding regimes. In spite of this, some
BFIs are promising candidates and can be used under some
circumstances for each of the exposures; these are outlined
and discussed below, in light of the eight validation criteria.
Table 1 should be used as an indicator of lacking evidence
for each candidate BFI that needs to be addressed in further
research.
Animal protein intake may be determined by the changes
in isotope ratios, i.e., δ15N and/or δ13C in urine, stool, hair
or blood. Dose-response for both ratios has been observed
for hair and whole blood. The repeated-dose time-response
was established for hair samples for a single individual indi-
cating that more than 5 months may be needed to change
levels in hair close to the scalp. The time-course for blood
has not been established, except that 1–4 weeks of dietary
change seems insufficient. Time-response for urine and
stool has not been established for single meals but for re-
peated intakes of diets based on animal or plant protein,
and it was shown that 8 days of change was enough to alter
the isotope ratios. The ratios in hair and blood are robust
since they have been successfully applied in experimental as
well as observational settings and they are reliable since
they have repeatedly been validated against other intake
measures, including dietary records and markers of aquatic
meat intake. Robustness and reliability have not yet been
established for the shorter-term markers in urine or stool.
The ratios are chemically and biologically stable since stable
isotopes cannot change with storage or handling and since
they are known to work also in archeology. Moreover, their
analytical performance is well established, their precision
and accuracy is high, and inter-individual variability low,
which has been observed in several laboratories, indicating
also good reproducibility in terms of absolute values. The
major weakness is the variation between populations due to
food matrix effects and the lack of knowledge about the
ability of the marker to pick up smaller differences in the
average intakes of animal protein in individuals. Overall,
the isotope ratios are excellent for comparing longer-term
overall animal protein intakes within a population but need
further refinement for measurements of shorter-term in-
takes or for estimating intakes accurately.
Total meat intake, including terrestrial and aquatic
meats, may be assessed at the group level by 3-MH in
blood or urine and potentially by anserine due to their
presence in poultry and/or fish; the most promising
markers of total meat intake at the individual level may
be creatine in blood or urine or Hyp in blood. The latter
(Hyp) may be a general marker of all meat since it re-
flects intake of cartilage, present also in offal. Dose-
response has been shown only for the markers in blood.
The measurements in blood seem robust and have been
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shown so far to associate with habitual intakes at the
group level. Plasma Hyp has also been associated with
meat intake in a few observational studies. Analytical per-
formance seems adequate for creatine, while Hyp exists
both free and as part of dipeptides and better validation is
needed for each of these or for their combination. There
are sparse data for validation of the individual variability,
shorter- and longer-term time-response, reliability, and re-
producibility of these markers. Urinary creatine has been
proposed as a marker of habitual meat intake, with good
robustness shown also in observational studies. Further
validation studies are needed to evaluate reliability of these
markers when different sources of meat are consumed.
Terrestrial meat (muscle) intake, including meat from
mammals and birds, may be assessed by quantifying car-
nosine in urine. Carnosine seems to reflect only terrestrial
meat intake, as it is absent in almost all aquatic meats.
The marker has been reported to show dose-response and
single meal time-response with no apparent accumulation
upon repeated daily intakes; thus it is only reflecting re-
cent meat intakes. The marker also seems robust in stud-
ies with a complex diet and it is strongly associated with
other dietary assessment, i.e., FFQs at the group level, al-
though there is still a paucity regarding the reliability at
the individual level. Chemical and biological stability in
urine and inter-laboratory reproducibility studies are also
lacking while analytical performance seems adequate with
LC-MS-based analytical platforms available for accurate
measurements. Carnosine in combination with 1- and 3-
MH, provided a better estimate of meat intake than each
of the compounds alone [275]. Even though this model
needs to be validated for reliability in observational stud-
ies, it underlines that measuring a combination of markers
could optimize dietary assessment of meat intake.
Intake of white meat, i.e., poultry, but also some species
of fish, may be assessed by the urinary excretion of 3-MH
or anserine, or by 3-MH in plasma. Anserine is present in
hen and turkey muscle and to a lesser extent in meat from
several species of fish, including cod, salmon and tuna; ex-
cretion in humans may therefore mainly reflect poultry in-
take, while more studies are needed to assess the influence
of fish on this marker. Human excretion of anserine has
been shown to be strongly associated only with chicken
intake and not with fish at the group level (high vs. non-
consumers) in a small European sub-study [38]. Anserine
excretion after dietary intake has acceptable analytical per-
formance in several analytical systems, stability after
longer-term storage, and robustness; but experimental evi-
dence for dose-response and time-response is still missing,
including for experimental studies with fish intake. On the
other hand, the validation of 3-MH in urine shows repro-
ducible dose-, and time-response in experimental studies,
although it is strongly associated with the intake of both
bird and fish meat in observational studies. Increased
excretion is also observed after red meat intake, albeit less
strongly [276]; even so, experimental studies showing
time- and dose-response of 3-MH excretion have been ob-
served after intake of beef [43]. Inter-individual variation
seems limited and background excretion rates with lacto-
ovo-vegetarian diets are low. Stability is excellent and ana-
lytical performance is good in systems able to discriminate
1- and 3-MH [277, 278], but more data are needed regard-
ing relative excretion levels after different sources of meat.
Postprandial plasma 3-MH has been shown to respond
stronger to chicken than to fish (haddock) with clear
dose-response but with only marginal increases after high
intakes of beef compared with other sources [38]. Plasma
or serum 3-MH has not been extensively used as a marker
in observational studies and most aspects of validation are
therefore still missing, needing further research. From the
scoring pattern, 3-MH in urine can be considered a valid
compliance marker of poultry intake but may reflect gen-
eral meat intake more broadly in samples from observa-
tional studies. Further validation studies are needed to
study the relationship of 3-MH excretion with different
kinds of aquatic meats.
Intake of cooked chicken may be quantified reliably by
urinary levels of guanidinoacetate, which shows good
dose-response, robustness, and analytical performance in
a recent study from UK and Ireland [46] using NMR; gua-
nidinoacetate in urine has also been observed in Denmark
after a diet with mixed foods, including chicken [113];
however, further validation is needed in relation to other
poultry meats and to potential geographical variation in
the contents of this compound in chicken meat.
Average intake of heated muscle food may be assessed
by the level of PhIP in hair while urinary excretion of
PhIP, 4-OH-PhIP or MeIQx after hydrolysis of conju-
gates may be markers of recent intakes. All markers can
be quantified reliably, while sample pretreatment (hy-
drolysis) strongly affects the measured concentrations.
Dose-response was shown experimentally for PhIP in
urine during a 4-day intervention showing little tendency
for metabolite accumulation. However, urinary markers
show large inter-individual variation. Only measure-
ments of MeIQx in urine showed some agreement with
FFQ-based estimations of cooked meat intakes in an ob-
servational study and MeIQx therefore seems as the
more robust and reliable of the two. 4′-OH-PhIP may
also be useful as a urinary marker of fried meat but lacks
most aspects of validation, thus needing further research.
Hair levels of PhIP show promise for estimating average
intakes of fried and grilled meat over several months
confirming levels in experimental diets with evidence of
dose-response; however, robustness and reliability in ob-
servational studies have not yet been documented.
Habitual intake of aquatic meats, including fish and
shellfish, or of fish oil, may be assessed by n-3 LCPUFA in
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whole blood, RBC, plasma or plasma phospholipids.
Among the metabolites associated with repeated or habit-
ual fish intake, EPA, DHA, and total n-3 LCPUFA have
shown reasonable ability to discriminate between terres-
trial meat and fish intake or to estimate consumption of
fish, shellfish, and fish oil supplements. EPA and DHA
levels in various fractions in blood have mainly been in-
vestigated after repetitive intakes, showing clear dose-
response with reported intakes; DHA was shown also to
increase in plasma after a single meal in studies with cod
or fish oil [95, 189], peaking at 2–4 h. In experimental
dietary studies, the time to reach steady state of LCPUFAs
after fish, shellfish, or fish oil was 2–6 weeks for whole
blood, plasma, and plasma lipids; 8 weeks for serum; and
4 weeks to 6 months for RBC. Total plasma free or esteri-
fied EPA and DHA were proved to be sufficiently robust
and all analytical criteria are fulfilled.
Recent intake of aquatic meats, including fish and
shellfish, may be assessed by several markers, including
CMPF, AsB, or TMAO in urine, and CMPF or LCPUFA
in plasma. CMPF and TMAO respond postprandially to
meals with fish, showing dose-response and time-
response. Complete excretion of TMAO within 24 h is
observed in subjects with normal renal function. CMPF
has a longer half-life in blood and is not completely ex-
creted in 24 h; in some groups of patients, the half-life
may reach 4 weeks but better kinetic data are needed
from experiments in healthy subjects. CMPF in blood
seems to be observed in most cross-sectional studies of
fish and shellfish intake while TMAO is not always asso-
ciated with these intakes when cod or crustaceans are
not an important part of the diets. CMPF seems there-
fore more reliable as a general fish marker in areas
where furan fatty acids are present in the food chain but
studies from additional areas of the world are needed to
explore whether this is common everywhere. Both
CMPF and TMAO are stable during storage, easily
quantified but excretion is affected by kidney function,
potentially making them reliable only in healthy subjects.
Inter-laboratory comparison studies are not yet pub-
lished but reported levels are comparable between la-
boratories, indicating fair reproducibility. AsB has
known short-term kinetics in plasma and urine but
repeated-dose experimental studies are still lacking. The
compound is likely to vary with geographical region and
cooking practices but has been shown to be reliable in
some regions, reflecting habitual intakes at the group
level measured by dietary records. The analytical per-
formance is sufficiently good to show clear kinetics by
untargeted measurements but formal analytical valid-
ation is lacking for urine as well as for plasma. Plasma
AsB has been determined in a single experimental study.
Much additional validation is therefore required for the
use of AsB as a biomarker of aquatic meat intake.
Conclusion
A range of biomarkers have potential to estimate meat
and fish intake. The δ15N and/or δ13C ratios in hair are
good determinants of long-term animal protein. Blood
levels of creatine, hydroxyproline, and 3-MH are promis-
ing markers of total meat while carnosine works for ter-
restrial meats. However, more studies are needed to
validate these markers, both alone and in combinations.
The best validated markers are DHA and EPA in blood,
serum, and blood lipids, clearly recognized as markers of
habitual oily fish consumption. CMPF in blood and
urine and TMAO in urine may also be useful markers to
measure fish intake but depend on dietary habits. Over-
all, fish markers need validation in different populations.
3-MH seems to be a good biomarker of poultry intake
showing dose-response, time-response, and good analyt-
ical performance but its robustness may be questioned
because intake of some fish and possibly other meats are
likely to interfere. Anserine is particularly good at char-
acterizing poultry in both intervention and observational
settings, but studies on time-response and dose-response
are lacking. Guanidinoacetate excretion in urine is a
promising new biomarker of chicken intake showing
dose-response and robustness. No robust markers have
been recognized so far to specifically assess red meat in-
take. BFIs able to discriminate between red and proc-
essed meats are also lacking. For fried and grilled meats,
MeIQx in hydrolyzed urine and PhIP in hair are candi-
date biomarkers but need further work for their full val-
idation. Additional studies on BFI discovery and
validation are therefore needed before we can reliably as-
sess or quantify intakes of all meat and most meat sub-
groups, except for aquatic n-3 LCPUFA.
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